ClinVar Miner

Submissions for variant NM_000251.3(MSH2):c.2027C>T (p.Ser676Leu)

dbSNP: rs1057520735
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 2
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Myriad Genetics, Inc. RCV003449402 SCV004186586 likely pathogenic Lynch syndrome 1 2023-08-07 criteria provided, single submitter clinical testing This variant is considered likely pathogenic. Functional studies indicate this variant impacts protein function [PMID: 33357406, 23690608]. This variant is expected to disrupt protein structure [Myriad internal data].
Department of Pathology and Laboratory Medicine, Sinai Health System RCV000501150 SCV000592528 uncertain significance Carcinoma of colon no assertion criteria provided clinical testing The MSH2 p.Ser676Leu variant was identified in the literature on studies on variants of unknown significance using an in-cellulo procedure to predict pathogenicity. MMR assays to test humanized variant MMR proteins were performed. The variant MMR/MAPP score from these studies was 28.64 predicting the variant to be pathogenic (Score >4.55 are pathogenic) (Drost 2013). The variant was also identified in COSMIC (2x) as somatic variants in tumour samples in liver carcinomas. The variant was not identified in the dbSNP, NHLBI Exome Sequencing Project, Exome Aggregation Consortium (14 March 2016), Clinvitae, “Mismatch Repair Genes Variant”, “MMR Gene Unclassified Variants ”, InSiGHT Colon Cancer Gene Variant (LOVD), Zhejiang Colon Cancer (LOVD), ClinVar, GeneInsight – COGR, and UMD databases. The p.Ser676 residue is conserved across mammals and other organisms, and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) suggest that the variant may impact the protein; however, this information is not predictive enough to assume pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) do not predict a difference in splicing. In summary, based on the above information, the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.